Heart failure in Krasnodar territory: Analysis of the current situation and ways of its improvement
Abstract. Heart failure (HF) is an outcome of many cardiovascular diseases (CVD). The high prevalence of HF emphasizes the importance of development and implementation of effective preventive measures, as well as using proven therapeutic strategies for adverse outcomes’ prevention. Current research work presents statistical data on the prevalence of heart failure in Krasnodar territory and analyzes factors contributing to the increase in the number of cases of the disease.Karibova M.V., Kruchinova S.V., Gendugova M.N., Kosmacheva E.D.
The aim: to describe the clinical portrait and treatment regimens of patients hospitalized in heart failure centers in Krasnodar territory based on registry data, to determine the incidence of in-hospital death rate and its correlation with initial clinical characteristics of patients.
Material and methods. The study included patients with heart failure hospitalized due to heart failure decompensation. The data of 5,525 people included in the Hospital Heart Failure Registry from 01.01.2022 to 01.01.2024 were analyzed.
Results. HF with a reducedejection fraction (HFrEF) was diagnosed in 51.7%, with moderately low EF – in 23%, with preserved EF – in 25.3% of patients. The most common causes of HF were ischemic heart disease, atrial fibrillation or flutter, and arterial hypertension. HF was most often accompanied by obesity (46.8%), chronic kidney disease (45%), anemia (37.2%), and hypercholesterolemia (35.8%). During hospitalization, lethal outcome occurred in 10.8% of cases, mainly in males with HFrEF (69.5%). These patients more often had arterial hypertension (85.1%), obesity (46%), and chronic kidney disease (44.8%).
Conclusion. Among patients with HF in Krasnodar territory, male individuals with HFrEF predominated. Relatively high average age of patients indicates a significant decrease in the risk of death from CVD at a young age and an increase in life expectancy due to achieved advances in the diagnosis and treatment of CVD. However, despite this, the use of reserves of treatment possibilities and the use of optimal multicomponent therapy for HFrEF in real practice are still remaining at a low level.
Keywords
heart failure
chronic heart failure registry
chronic heart failure treatment center
References
1. Li X.-M., Gao X.-Y., Tse G. et al. Electrocardiogram-based artificial intelligence for the diagnosis of heart failure: A systematic review and meta-analysis. J Geriatr Cardiol. 2022; 19(12): 970–80.
https://doi.org/10.11909/j.issn.1671-5411.2022.12.002. PMID: 36632204. PMCID: PMC9807402.
2. Фомин И.В. Хроническая сердечная недостаточность в российской федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016; 21(8): 7–13. (Fomin I.V. Chronic heart failure in Russian Federation: What do we know and what to do. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2016; 21(8): 7–13 (In Russ.)).
https://doi.org/10.15829/1560-4071-2016-8-7-13. EDN: WHURET.
3. Фролова Э.Б., Яушев М.Ф. Современное представление о хронической сердечной недостаточности. Вестник современной клинической медицины. 2013; 6(2): 87–93. (Frolova E.B., Yaushev M.F. Current understanding of chronic heart failure. Vestnik sovremennoy klinicheskoy meditsiny = The Bulletin of Contemporary Clinical Medicine. 2013; 6(2): 87–93 (In Russ.)). EDN: QBBQZP.
4. Беленков Ю.Н., Агеев Ф.Т. Эпидемиология и прогноз хронической сердечной недостаточности. РМЖ. 1999; (2): 51–55. (Belenkov Yu.N., Ageev F.T. Epidemiology and prognosis of chronic heart failure. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 1999; (2): 51–55 (In Russ.)).
5. Benjamin E.J., Virani S.S., Callaway C.W. et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2018 Update: A report from the American Heart Association. Circulation. 2018; 137(12): e67–e492.
https://doi.org/10.1161/CIR.0000000000000558. PMID: 29386200.
6. Groenewegen A., Rutten F.H., Mosterd A., Hoes A.W. Epidemiology of heart failure. Eur J Heart Fail. 2020; 22(8): 1342–56.
https://doi.org/10.1002/ejhf.1858. PMID: 32483830. PMCID: PMC7540043.
7. Stolfo D., Lund L.H., Benson L. et al. Persistent high burden of heart failure across the ejection fraction spectrum in a nationwide setting. J Am Heart Assoc. 2022; 11(22): e026708.
https://doi.org/10.1161/JAHA.122.026708. PMID: 36326055. PMCID: PMC9750084.
8. Jencks S.F., Williams M.V., Coleman E.A. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360(14): 1418–28.
https://doi.org/10.1056/NEJMsa0803563. PMID: 19339721.
9. Dharmarajan K., Hsieh A.F., Lin Z. et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013; 309(4): 355–63.
https://doi.org/10.1001/jama.2012.216476. PMID: 23340637. PMCID: PMC3688083.
10. Patil S., Shah M., Patel B. et al. Readmissions among patients admitted with acute decompensated heart failure based on income quartiles. Mayo Clin Proc. 2019; 94(10): 1939–50.
https://doi.org/10.1016/j.mayocp.2019.05.027. PMID: 31585578.
11. Cho H., Oh S.-H., Lee H. et al. The incremental economic burden of heart failure: A population-based investigation from South Korea. PLoS One. 2018; 13(12): e0208731.
https://doi.org/10.1371/journal.pone.0208731. PMID: 30576328. PMCID: PMC6303080.
12. Bundgaard J.S., Mogensen U.M., Christensen S. et al. The economic burden of heart failure in Denmark from 1998 to 2016. Eur J Heart Fail. 2019; 21(12): 1526–31.
https://doi.org/10.1002/ejhf.1577. PMID: 31359583.
13. Драпкина О.М., Бойцов С.А., Омельяновский В.В. с соавт. Социально-экономический ущерб, обусловленный хронической сердечной недостаточностью, в Российской Федерации. Российский кардиологический журнал. 2021; 26(6): 81–89. (Drapkina O.M., Boytsov S.A., Omelyanovskiy V.V. et al. Socio-economic impact of heart failure in Russia. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2021; 26(6): 81–89 (In Russ.)).
https://doi.org/10.15829/1560-4071-2021-4490. EDN: PUEROH.
14. Maggioni A.P., Dahlstrom U., Filippatos G. et al.; Heart Failure Association of the European Society of Cardiology (HFA). EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013; 15(7): 808–17.
https://doi.org/10.1093/eurjhf/hft050. PMID: 23537547.
15. Solomon S.D., Dobson J., Pocock S. et al.; Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007; 116(13): 1482–87.
https://doi.org/10.1161/circulationaha.107.696906. PMID: 17724259.
16. Lopatin Y., Rosano G.M.C. Treatment of patients in the vulnerable phase (at discharge or early after discharge). Int Cardiovasc Forum J. 2017; 10: 37–40.
https://doi.org/10.17987/icfj.v10i0.444.
17. Greene S.J., Fonarow G.C., Vaduganathan M. et al. The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol. 2015; 12(4): 220–29.
https://doi.org/10.1038/nrcardio.2015.14. PMID: 25666406.
18. Hamo C.E., Butler J., Gheorghiade M., Chioncel O. The bumpy road to drug development for acute heart failure. Eur Heart J Suppl. 2016; 18(suppl G): G19–G32.
https://doi.org/10.1093/eurheartj/suw045.
19. Fiuzat M., Ezekowitz J., Alemayehu W. et al. Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT trial: A secondary analysis of a randomized clinical trial. JAMA Cardiol. 2020; 5(7): 757–64.
https://doi.org/10.1001/ jamacardio.2020.0640. PMID: 32319999. PMCID: PMC7177636.
20. Фомин И.В., Краием Н., Поляков Д.С. с соавт. Понятие стабильности течения ХСН – приемлемо ли оно для российской практики? Кардиология. 2018; 58(S3): 55–63. (Fomin I.V., Kraiem N., Polyakov D.S. et al. The notion of CHF course stability: Is it acceptable for Russian practice? Kardiologiya = Cardiology. 2018; 58(S3): 55–63 (In Russ.))
https://doi.org/10.18087/cardio.2356. EDN: XMGTZB.
21. Виллевальде С.В., Соловьева А.Е., Звартау Н.Э. с соавт. Принципы организации медицинской помощи пациентам с сердечной недостаточностью в системе управления сердечно-сосудистыми рисками: фокус на преемственность и маршрутизацию пациентов. Практические материалы. Российский кардиологический журнал. 2021; 26(S3): 102–141. (Villevalde S.V., Soloveva A.E., Zvartau N.E. et al. Principles of organization of medical care for patients with heart failure in the system of cardiovascular risk management: Focus on continuity of care and patient routing. Practical materials. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2021; 26(3S): 102–141 (In Russ.)).
https://doi.org/10.15829/1560-4071-2021-4558. EDN: LYNDGX.
22. Шляхто Е.В., Звартау Н.Э., Виллевальде С.В. с соавт. Реализованные модели и элементы организации медицинской помощи пациентам с сердечной недостаточностью в регионах Российской Федерации: перспективы трансформации в региональные системы управления сердечно-сосудистыми рисками. Российский кардиологический журнал. 2020; 25(4): 9–18. (Shlyakhto E.V., Zvartau N.E., Villevalde S.V. et al. Implemented models and elements for heart failure care in the regions of the Russian Federation: Prospects for transformation into regional cardiovascular risk management systems. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25(4): 9–18 (In Russ.)).
https://doi.org/10.15829/1560-4071-2020-4-3792. EDN: EGQYDD.
23. Ситникова М.Ю., Лясникова Е.А., Трукшина М.А. Хроническая сердечная недостаточность: эпидемиология и перспективы планирования. Журнал сердечная недостаточность. 2012; 13(6): 372–376. (Sitnikova M.Yu., Lyasnikova E.A., Trushkina M.A. Chronic heart failure: Epidemiology and planning prospects. Zhurnal serdechnaya nedostatochnost’ = Russian Heart Failure Journal. 2012; 6(74): 372–376 (In Russ.)). EDN: PUNAJH.
24. Терещенко С.Н., Галявич А.С., Ускач Т.М. с соавт. Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(11): 311–374. (Tereshchenko S.N., Galyavich A.S., Uskach T.M. et al. 2020 Clinical practice guidelines for chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25(11): 311–374 (In Russ.)).
https://doi.org/10.15829/1560-4071-2020-4083. EDN: LJGGQV.
25. Галявич А.С., Терещенко С.Н., Ускач Т.М. с соавт. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024; 29(11): 251–349. (Galyavich A.S., Tereshchenko S.N., Uskach T.M. et al. 2024 Clinical practice guidelines for Chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2024; 29(11): 251–349 (In Russ.)).
https://doi.org/10.15829/1560-4071-2024-6162. EDN: WKIDLJ.
26. Мареев В.Ю., Фомин И.В., Агеев Ф.Т. с соавт. Клинические рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018; 58(S6): 8–158. (Mareev V.Yu., Fomin I.V., Ageev F.T. et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: Chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiya. 2018; 58(S6): 8–158 (In Russ.)).
https://doi.org/10.18087/cardio.2475. EDN: XUAREL.
27. Senni M., Gavazzi A., Oliva F. et al.; IN HF Outcome Investigators. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry. Int J Cardiol. 2014; 173(2): 163–9.
https://doi.org/10.1016/j.ijcard.2014.02.018. PMID: 24630337.
28. Mant J., Doust J., Roalfe A. et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess. 2009; 13(32): 1–207, iii.
https://doi.org/10.3310/hta13320. PMID: 19586584.
29. Терещенко С.Н., Жиров И.В., Нарусов О.Ю. с соавт. Диагностика и лечение хронической и острой сердечной недостаточности. Кардиологический вестник. 2016; 11(2): 3–33. (Tereshchenko S.N., Zhirov I.V., Narusov O.Yu. et al. Diagnosis and treatment of chronic and acute heart failure. Kardiologicheskiy vestnik = Russian Cardiology Bulleti. 2016; 11(2): 3–33 (In Russ.)). EDN: WAHDJD.
30. Johansen N.D., Vaduganathan M., Zahir D. et al. A composite score summarizing use and dosing of evidence-based medical therapies in heart failure: A nationwide cohort study. Circ Heart Fail. 2023; 16(2): e009729.
https://doi.org/10.1161/circheartfailure.122.009729. PMID: 36809039.
31. Шляхто Е.В., Беленков Ю.Н., Бойцов С.А. с соавт. Результаты промежуточного анализа проспективного наблюдательного многоцентрового регистрового исследования пациентов с хронической сердечной недостаточностью в Российской Федерации «ПРИОРИТЕТ-ХСН»: исходные характеристики и лечение первых включенных пациентов. Российский кардиологический журнал. 2023; 28(10): 93–103. (Shlyakhto E.V., Belenkov Yu.N., Boytsov S.A. et al. Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation “PRIORITET-CHF”: Initial characteristics and treatment of the first included patients. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2023; 28(10): 93–103 (In Russ.)).
https://doi.org/10.15829/1560-4071-2023-5593. EDN: AMDHTV.
32. Шляхто Е.В., Беленков Ю.Н., Бойцов С.А. с соавт. Проспективное наблюдательное многоцентровое регистровое исследование пациентов с хронической сердечной недостаточностью в Российской Федерации (ПРИОРИТЕТ-ХСН): обоснование, цели и дизайн исследования. Российский кардиологический журнал. 2023; 28(6): 7–14. (Shlyakhto E.V., Belenkov Yu.N., Boytsov S.A. et al. Prospective observational multicenter registry study of patients with heart failure in the Russian Federation (PRIORITET-CHF): Rationale, objectives and design of the study. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2023; 28(6): 7–14 (In Russ.)).
https://doi.org/10.15829/1560-4071-2023-5456. EDN: LKSHVP.
33. Поляков Д.С., Фомин И.В., Беленков Ю.Н. с соавт. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021; 61(4): 4–14. (Polyakov D.S., Fomin I.V., Belenkov Yu.N. et al. Chronic heart failure in the Russian Federation: What has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiya = Cardiology. 2021; 61(4): 4–14 (In Russ.)).
https://doi.org/10.18087/cardio.2021.4.n1628. EDN: WSZNFS.
About the Authors
Maria V. Karibova, postgraduate student of the Department of therapy No. 1, Kuban State Medical University of the Ministry of Healthcare of Russia, cardiologist at Professor S.V. Ochapovsky Research Institute – Regional Clinical Hospital No. 1. Address: 350086, Krasnodar, 167 Pervogo Maya St.E-mail: mari.karibova96@mail.ru
ORCID: https://orcid.org/0009-0003-0159-9182. Scopus ID: 59303665000. eLibrary SPIN: 7954-2943
Sofia V. Kruchinova, MD, PhD (Medicine), associate professor of the Department of therapy No. 1, Kuban State Medical University of the Ministry of Healthcare of Russia, cardiologist at Professor S.V. Ochapovsky Research Institute – Regional Clinical Hospital No. 1. Address: 350086, Krasnodar, 167 Pervogo Maya St.
E-mail: skruchinova@mail.ru
ORCID: https://orcid.org/0000-0002-7538-0437. Scopus ID: 57208866488. eLibrary SPIN: 8762-1737
Milana N. Gendugova, postgraduate student of the Department of therapy No. 1, Kuban State Medical University of the Ministry of Healthcare of Russia, cardiologist at Professor S.V. Ochapovsky Research Institute – Regional Clinical Hospital No. 1. Address: 350086, Krasnodar, 167 Pervogo Maya St.
E-mail: milana.gendugova@mail.ru
ORCID: https://orcid.org/0009-0009-7063-3798
Elena D. Kosmacheva, MD, Dr. Sci. (Medicine), professor, head of the Department of therapy No. 1, Kuban State Medical University of the Ministry of Healthcare of Russia, deputy chief physician for medical work of Professor S.V. Ochapovsky Research Institute – Regional Clinical Hospital No. 1. Address: 350086, Krasnodar, 167 Pervogo Maya St.
E-mail: kosmachova_h@mail.ru
ORCID: https://orcid.org/0000-0001-8600-0199. Scopus ID: 6603083943. eLibrary SPIN: 5277-2982
Similar Articles
